GSK invites private equity to bid for older drugs: Reuters

GlaxoSmithKline (GSK.L) has invited private equity firms to consider making offers for a range of its older drugs sold in Western markets, Reuters reported, citing three people with direct knowledge of the matter.

DealsNorth AmericaUS